Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

665243.pdf (144.34 KB)

Document type

Article

Version

Accepted version

Publication date

2016-08-15

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/160518

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1093/cid/ciw245

Abstract

The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.

Subject

Pneumònia, Assaigs clínics de medicaments

Subject (English)

Pneumonia, Drug testing

Citation

Collections

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

FRANÇOIS, Bruno, et al. The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia. Clinical Infectious Diseases. 2016. Vol. 63, num. Suppl 2, pags. S46-S51. ISSN 1058-4838. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/160518

Export metadata

JSON - METS

Share record